SG11201602256UA - Production method for diazabicyclooctane derivative and intermediary body thereof - Google Patents
Production method for diazabicyclooctane derivative and intermediary body thereofInfo
- Publication number
- SG11201602256UA SG11201602256UA SG11201602256UA SG11201602256UA SG11201602256UA SG 11201602256U A SG11201602256U A SG 11201602256UA SG 11201602256U A SG11201602256U A SG 11201602256UA SG 11201602256U A SG11201602256U A SG 11201602256UA SG 11201602256U A SG11201602256U A SG 11201602256UA
- Authority
- SG
- Singapore
- Prior art keywords
- production method
- intermediary body
- diazabicyclooctane derivative
- diazabicyclooctane
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013197110 | 2013-09-24 | ||
| PCT/JP2014/075203 WO2015046207A1 (ja) | 2013-09-24 | 2014-09-24 | ジアザビシクロオクタン誘導体の製造法とその中間体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201602256UA true SG11201602256UA (en) | 2016-04-28 |
Family
ID=52743343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201602256UA SG11201602256UA (en) | 2013-09-24 | 2014-09-24 | Production method for diazabicyclooctane derivative and intermediary body thereof |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US10000491B2 (de) |
| EP (1) | EP3050883B1 (de) |
| JP (1) | JP6453222B2 (de) |
| KR (1) | KR102239725B1 (de) |
| CN (2) | CN107501264A (de) |
| AR (1) | AR097744A1 (de) |
| AU (1) | AU2014324302B2 (de) |
| BR (1) | BR112016006246B8 (de) |
| CA (1) | CA2924953C (de) |
| DK (1) | DK3050883T3 (de) |
| ES (1) | ES2793201T3 (de) |
| HK (2) | HK1219473A1 (de) |
| HU (1) | HUE049027T2 (de) |
| IL (1) | IL244740B (de) |
| MX (1) | MX367578B (de) |
| MY (2) | MY176278A (de) |
| NZ (1) | NZ718009A (de) |
| RU (1) | RU2719480C2 (de) |
| SG (1) | SG11201602256UA (de) |
| TW (1) | TWI644908B (de) |
| WO (1) | WO2015046207A1 (de) |
| ZA (1) | ZA201602053B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2874279C (en) | 2012-05-30 | 2021-03-16 | Meiji Seika Pharma Co., Ltd. | Diazabicyclooctane derivatives useful as .beta.-lactamase inhibitor and process for preparing the same |
| SG11201602256UA (en) | 2013-09-24 | 2016-04-28 | Meiji Seika Pharma Co Ltd | Production method for diazabicyclooctane derivative and intermediary body thereof |
| SG11201602723RA (en) * | 2013-10-08 | 2016-05-30 | Meiji Seika Pharma Co Ltd | Crystals of diazabicyclooctane derivative and production method for crystals of diazabicyclooctane derivative |
| TWI691499B (zh) * | 2014-12-05 | 2020-04-21 | 日商明治製菓藥業股份有限公司 | 二氮雜雙環辛烷衍生物之結晶及安定的凍結乾燥製劑的製造法 |
| CA2944306C (en) | 2015-10-30 | 2023-11-14 | The Toronto-Dominion Bank | Validating encrypted data from a multi-layer token |
| US11216808B2 (en) | 2015-11-04 | 2022-01-04 | The Toronto-Dominion Bank | Token-based system for excising data from databases |
| JP2020011901A (ja) * | 2016-10-20 | 2020-01-23 | 協和キリン株式会社 | ピロリジン化合物の製造方法 |
| CN106699756B (zh) * | 2016-12-30 | 2019-10-29 | 淄博鑫泉医药技术服务有限公司 | β内酰胺酶抑制剂阿维巴坦的合成方法 |
| KR20200091394A (ko) | 2017-09-27 | 2020-07-30 | 페도라 파마슈티칼스 인코포레이티드 | 디아자비시클로옥탄 유도체의 약제학적 형태 및 그의 제조방법 |
| JP7179058B2 (ja) | 2017-09-27 | 2022-11-28 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | ジアザビシクロオクタン誘導体の剤形およびその生産プロセス |
| KR20200091395A (ko) | 2017-09-27 | 2020-07-30 | 페도라 파마슈티칼스 인코포레이티드 | 디아자비시클로옥탄 유도체의 결정형 및 그의 제조 방법 |
| CN109678856B (zh) * | 2017-10-18 | 2020-09-25 | 新发药业有限公司 | 一种阿维巴坦中间体的制备方法 |
| JP7289836B2 (ja) | 2017-11-23 | 2023-06-12 | エフ． ホフマン－ラ ロシュ アーゲー | プロリンヒドロキシラーゼ、ならびにそれに伴う使用、方法および生成物 |
| WO2020018462A1 (en) | 2018-07-16 | 2020-01-23 | Brown University | A chromogenic beta-lactamase substrate |
| EP3854786A4 (de) * | 2018-09-21 | 2022-09-14 | API Corporation | Verfahren zur herstellung von aminosäurederivaten |
| WO2021038403A1 (en) | 2019-08-30 | 2021-03-04 | DePuy Synthes Products, Inc. | Electrical device for monitoring, prevention, and treatment of implant infections |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5038509B1 (de) | 1970-10-21 | 1975-12-10 | ||
| JPS538509A (en) | 1976-07-13 | 1978-01-26 | Toshiba Corp | Impedance matching system for data transmission circuit |
| GB1589317A (en) | 1977-11-24 | 1981-05-13 | Lilly Co Eli | Freeze drying cephalothin sodium |
| JPS6019759B2 (ja) | 1977-11-24 | 1985-05-17 | イ−ライ・リリ−・アンド・カンパニ− | 非経口投予用１１１１５１５２１３９１９９東京都中央区京橋２丁目３番１３号 |
| JPS60255723A (ja) | 1984-05-31 | 1985-12-17 | Ono Pharmaceut Co Ltd | メシル酸ガベキサートの結晶性凍結乾燥製剤及びその製造方法 |
| JPH07117533B2 (ja) | 1985-08-28 | 1995-12-18 | 株式会社生体科学研究所 | トランスフエリンおよびその用途 |
| US20030220521A1 (en) | 1989-07-27 | 2003-11-27 | G.D. Searle & Co. | Renal-selective prodrugs for control of renal sympathetic nerve activity in the treatment of hypertension |
| TW264475B (de) | 1991-09-20 | 1995-12-01 | Takeda Pharm Industry Co Ltd | |
| KR100197454B1 (ko) * | 1993-12-29 | 1999-06-15 | 디. 제이. 우드, 스피겔 알렌 제이 | 디아자비시클릭 뉴로키닌 길항제 |
| JP2843444B2 (ja) | 1994-05-02 | 1999-01-06 | 塩野義製薬株式会社 | ピロリジルチオカルバペネム誘導体の結晶，該結晶を含む凍結乾燥製剤，およびその製造方法 |
| ES2183874T3 (es) | 1994-05-02 | 2003-04-01 | Shionogi & Co | Cristal derivado de pirrolidylthiocarbapenem, preparado liofilizado conteniendo dicho cristal y procedimiento para su produccion. |
| FR2812635B1 (fr) | 2000-08-01 | 2002-10-11 | Aventis Pharma Sa | Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens |
| FR2815420B1 (fr) | 2000-10-16 | 2003-05-16 | Cit Alcatel | Compensation de la dispersion chromatique dans un systeme de transmission a fibre optique, et fibre de compensation |
| FR2825705B1 (fr) | 2001-06-08 | 2005-05-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
| FR2835186B1 (fr) | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
| FR2921060B1 (fr) | 2007-09-14 | 2012-06-15 | Novexel | Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires |
| DK2231667T3 (da) | 2008-01-18 | 2013-12-16 | Merck Sharp & Dohme | Beta-lactamase-hæmmere |
| FR2930553B1 (fr) | 2008-04-29 | 2010-05-21 | Novexel | Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment inhibiteurs de beta-lactamases |
| FR2936798B1 (fr) | 2008-10-03 | 2012-09-28 | Novexel | Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens. |
| WO2010126820A2 (en) * | 2009-04-30 | 2010-11-04 | Merck Sharp & Dohme Corp. | Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids |
| FR2951171A1 (fr) | 2009-10-09 | 2011-04-15 | Novexel | Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation |
| JP2012122603A (ja) | 2010-11-15 | 2012-06-28 | Nifco Inc | コネクタ装置 |
| HUE032491T2 (en) * | 2010-12-22 | 2017-09-28 | Meiji Seika Pharma Co Ltd | An optically active diaza-bicyclooctane derivative and a process for its preparation |
| US8772490B2 (en) | 2010-12-22 | 2014-07-08 | Meiji Seika Pharma Co., Ltd. | Optically active diazabicyclooctane derivatives and process for preparing the same |
| TWI565706B (zh) | 2011-06-17 | 2017-01-11 | 阿斯特捷利康公司 | 用於製備包括反－７－酮基－６－（磺酸氧基）－１，６－二氮雜雙環［３，２，１］辛烷－２－甲醯胺之雜環化合物及其鹽類之方法 |
| RU2636147C1 (ru) | 2011-08-27 | 2017-11-21 | Вокхардт Лимитед | Производные 1,6-диазабицикло[3,2,1]октан-7-она и их применение при лечении бактериальных инфекционных болезней |
| ES2606059T3 (es) | 2011-08-30 | 2017-03-17 | Wockhardt Limited | Derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona y su uso en el tratamiento de infecciones bacterianas |
| ES2640520T3 (es) | 2011-09-13 | 2017-11-03 | Wockhardt Limited | Compuestos que contienen nitrógeno y su uso |
| US8796257B2 (en) | 2011-12-02 | 2014-08-05 | Naeja Pharmaceutical Inc. | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors |
| US9505761B2 (en) | 2011-12-02 | 2016-11-29 | Fedora Pharmaceuticals Inc. | Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors |
| CA2874279C (en) | 2012-05-30 | 2021-03-16 | Meiji Seika Pharma Co., Ltd. | Diazabicyclooctane derivatives useful as .beta.-lactamase inhibitor and process for preparing the same |
| SG11201602256UA (en) | 2013-09-24 | 2016-04-28 | Meiji Seika Pharma Co Ltd | Production method for diazabicyclooctane derivative and intermediary body thereof |
| SG11201602723RA (en) | 2013-10-08 | 2016-05-30 | Meiji Seika Pharma Co Ltd | Crystals of diazabicyclooctane derivative and production method for crystals of diazabicyclooctane derivative |
-
2014
- 2014-09-24 SG SG11201602256UA patent/SG11201602256UA/en unknown
- 2014-09-24 JP JP2015539238A patent/JP6453222B2/ja active Active
- 2014-09-24 MX MX2016003867A patent/MX367578B/es active IP Right Grant
- 2014-09-24 WO PCT/JP2014/075203 patent/WO2015046207A1/ja active Application Filing
- 2014-09-24 RU RU2016115767A patent/RU2719480C2/ru active
- 2014-09-24 AU AU2014324302A patent/AU2014324302B2/en active Active
- 2014-09-24 US US15/023,976 patent/US10000491B2/en active Active
- 2014-09-24 NZ NZ718009A patent/NZ718009A/en unknown
- 2014-09-24 MY MYPI2016700980A patent/MY176278A/en unknown
- 2014-09-24 EP EP14847854.8A patent/EP3050883B1/de active Active
- 2014-09-24 MY MYPI2019004461A patent/MY193210A/en unknown
- 2014-09-24 ES ES14847854T patent/ES2793201T3/es active Active
- 2014-09-24 CN CN201710665418.8A patent/CN107501264A/zh active Pending
- 2014-09-24 BR BR112016006246A patent/BR112016006246B8/pt active IP Right Grant
- 2014-09-24 KR KR1020167009769A patent/KR102239725B1/ko active IP Right Grant
- 2014-09-24 CA CA2924953A patent/CA2924953C/en active Active
- 2014-09-24 CN CN201480052097.9A patent/CN105555787B/zh active Active
- 2014-09-24 AR ARP140103525A patent/AR097744A1/es active IP Right Grant
- 2014-09-24 DK DK14847854.8T patent/DK3050883T3/da active
- 2014-09-24 HU HUE14847854A patent/HUE049027T2/hu unknown
- 2014-09-24 TW TW103132937A patent/TWI644908B/zh active
-
2016
- 2016-03-23 IL IL244740A patent/IL244740B/en active IP Right Grant
- 2016-03-29 ZA ZA2016/02053A patent/ZA201602053B/en unknown
- 2016-06-24 HK HK16107390.3A patent/HK1219473A1/zh unknown
- 2016-06-24 HK HK18103950.2A patent/HK1244487A1/zh unknown
-
2017
- 2017-06-05 US US15/613,620 patent/US10000492B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1219473A1 (zh) | 二氮雜二環辛烷衍生物的製備方法及其中間體 | |
| EP2987649A4 (de) | Reifen und verfahren zur herstellung des reifens | |
| HK1219479A1 (zh) | 二氮雜二環辛烷衍生物的結晶及其製備方法 | |
| EP2987650A4 (de) | Reifen und verfahren zur herstellung des reifens | |
| EP2947416A4 (de) | Sensor und verfahren zur herstellung davon | |
| EP3081746A4 (de) | Rotierender körper und verfahren zur herstellung des rotierenden körpers | |
| EP2974766A4 (de) | Ballon und herstellungsverfahren dafür | |
| PL2991817T3 (pl) | Sposób dopasowywania i sposób wytwarzania dla elementów konstrukcyjnych wytwarzanych za pomocą SLM | |
| EP3009400A4 (de) | Lev-zeolith und herstellungsverfahren dafür | |
| LT3043814T (lt) | Antigenas ir jo gamybos būdas | |
| EP2990072A4 (de) | Herstellungsverfahren für nadelförmige körper | |
| AP2016009136A0 (en) | A method for the treatment of metals | |
| EP3010699A4 (de) | Verfahren zur herstellung eines bauteiles und herstellungsvorrichtung dafür | |
| IL241096A0 (en) | Treatment methods | |
| IL245749B (en) | An n-phenyldiacrylimide derivative containing bromine is a method for its preparation | |
| EP3045442A4 (de) | Verfahren zur herstellung von cyclolavandulol und derivat davon | |
| EP3045443A4 (de) | Verfahren zur herstellung von cyclolavandulal und derivat davon | |
| PL3041506T3 (pl) | Sposób leczenia | |
| GB2515780B (en) | Cremation process and apparatus | |
| EP2960030A4 (de) | Herstellungsverfahren und herstellungsvorrichtung für eine vorform | |
| GB201319281D0 (en) | Bed and method of manufacture thereof | |
| GB201300367D0 (en) | Method of calibrating neural asynchronies | |
| GB201322778D0 (en) | Method of treatment | |
| EP2957649A4 (de) | Gleitelement und herstellungsverfahren für gleitelement | |
| GB201314882D0 (en) | Method of treatment |